NCT04149431View on ClinicalTrials.gov

Multicenter Study to Evaluate Efficacy, Tolerability, Safety of Derinat

PHASE3UnknownINTERVENTIONAL

Enrollment

350

Participants

Timeline

Start Date

December 15, 2019

Primary Completion Date

May 31, 2022

Study Completion Date

May 31, 2022

Conditions

Respiratory Infections in Children

Interventions

DRUG

Derinat

desoxyribonucleate sodium

Trial Locations (1)

Unknown

Irina Gerasimova, Moscow

Sponsors

Lead Sponsor

All Listed Sponsors

lead

PharmPak, LLC

INDUSTRY